Research Topics
Species | Per LjungmanSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsP Ljungman
Department of Haematology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Br J Haematol 111:774-81. 2000..04) influenced HHV-6 DNA levels. HHV-6 viral load was significantly correlated with delayed platelet engraftment in both univariate (P < 0.01) and multivariate analysis, and to the number of platelet transfusions...
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman
Department of Hematology, Karolinska University Hospital, S 14186 Stockholm, Sweden
Infect Dis Clin North Am 24:319-37. 2010..This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined...
Risk assessment in haematopoietic stem cell transplantation: viral statusPer Ljungman
Hematology Center, Karolinska University Hospital, Karolinska Institute, SE 14186 Stockholm, Sweden
Best Pract Res Clin Haematol 20:209-17. 2007..The aim of this review is to describe current knowledge regarding recipient and donor serological status for viral infections...
Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipientsP Ljungman
Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 39:497-9. 2007..49 (s.e. 0.31) log(10)/week in patients receiving ganciclovir whereas it increased 0.15 (s.e. 0.17) log(10)/week in episodes without antiviral therapy (P=0.04). We conclude that ganciclovir can decrease the HHV-6 viral load in saliva...
Molecular monitoring of viral infections after hematopoietic stem cell transplantationPer Ljungman
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Int J Hematol 91:596-601. 2010..Standardized assays are lacking for these viruses and additional studies are needed...
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman
Department of Haematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 45:219-34. 2010..The introduction of alternative therapies, such as imatinib for CML, has challenged well-established indications. An updated report with revised tables and operating definitions is presented...
Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donorsPer Ljungman
Hematology Center, Karolinska University Hospital, Stockholm, Sweden
Haematologica 92:1139-42. 2007..Adjusted for patient serostatus, the risk of a donor being seropositive was higher in females (p<0.001) and older donors (p<0.001)...
Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patientsPer Ljungman
Hematology Center, Karolinska University Hospital, S 14186 Stockholm, Sweden
J Clin Virol 35:493-5. 2006..Several techniques have been used and each has advantages and disadvantages...
CMV infections after hematopoietic stem cell transplantationP Ljungman
Department of Hematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 42:S70-S72. 2008..v. ganciclovir combined with high-dose Ig, but this standard has never been evaluated in a controlled study and more recent studies have questioned whether the addition of Ig improves outcome...
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipientsPer Ljungman
Dept of Haematology, Karolinska University Hospital, Stockholm, Sweden
Haematologica 96:1231-5. 2011..3%) died from A/H1N1 infection or its complications. Neutropenia (P=0.03) and patient age (P=0.04) were significant risk factors for death. The 2009 A/H1N1 influenza pandemic caused severe complications in stem cell transplant recipients...
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCTP Ljungman
Department of Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 42:227-40. 2008..Works presented only as abstracts were used to a very limited extent. The quality of evidence and level of recommendation were graded according to the Center for Disease Control (CDC) criteria...
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirusKajsa Larsson
Division for Hematology, Department of Medicine, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Transplantation 77:526-31. 2004..The aim of this study was to investigate the relationship between cytomegalovirus (CMV) and extensive chronic graft-versus-host disease (GvHD) after allogeneic stem-cell transplantation (SCT)...
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donorsPetter Svenberg
Centre for Allogenic Stem Cell Transplantation, Department of Paediatrics, Karolinska University Hospital, Huddinge, SE 14186 Stockholm, Sweden
Biol Blood Marrow Transplant 10:877-82. 2004..We conclude that HSCT with HLA-A, -B, and -DRbeta1 genomically matched unrelated donors in combination with antithymocyte globulin in the conditioning regimen gives encouraging results in patients with SAA or IEM...
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centerOlle Ringden
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 81:718-25. 2006..Allogeneic hematopoietic stem cell transplantation (ASCT) is a possible cure for many inherited disorders...
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantationPer Ljungman
Hematology Center, Karolinska University Hospital, SE 14186 Stockholm, Sweden
Haematologica 91:78-83. 2006..Cytomegalovirus (CMV) disease remains an important complication of allogeneic stem cell transplantation (SCT). We studied viral load kinetics and correlated the viral load and other transplant factors with the development of CMV disease...
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantationAndreas T Björklund
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Blood 115:2686-94. 2010..Our results provide evidence against the emergence of alloreactive NK cells in HLA-identical allogeneic SCT...
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysisPer Ljungman
Department of Hematology, Huddinge University Hospital, SE 14186 Stockholm, Sweden
Blood 102:4255-60. 2003..Our data suggest that donor CMV status influences outcome of unrelated SCT. For a CMV-seropositive patient, a seropositive donor might be preferable...
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 8:674-82. 2002..Patients with previous acute GVHD grades II to IV may benefit from more aggressive initial treatment. This possibility would have to be examined in clinical trials...
Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcomeGayane Avetisyan
Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Transplantation 88:1222-6. 2009..We aimed to determine the frequency, risk factors, and outcome of RSV infection in allo-HSCT recipients...
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpBKatarina Westling
Department of Medicine, Division of Infectious Diseases, I 73, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden
J Infect 56:204-10. 2008....
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignanciesKatarina Le Blanc
Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 15:1108-15. 2009..81, P=.02) and aGVHD (HR 0.84, P=.05). These results indicate that LC30 is an independent prognostic factor for transplant outcome in matched unrelated SCT for myelogenous malignancies...
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusionsDarius Sairafi
Center for Allogeneic Stem Cell Transplantation, Department of Medicine at Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Biol Blood Marrow Transplant 16:1728-37. 2010..In contrast, time between ASCT and start of DLI treatment had no significant influence on the risk of developing aGVHD. To conclude, monitoring of leukemia lineage-specific chimerism is of utmost importance for DLI response after ASCT...
Prevention and treatment of viral infections in stem cell transplant recipientsPer Ljungman
Department of Haematology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Br J Haematol 118:44-57. 2002
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?Olle Ringden
Centre for Allogeneic Stem Cell Transplantation, Division of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 10:128-34. 2004..The 5-year survival was 72%, 48%, and 30% with 0, 1, and 2 risk factors, respectively. We concluded that unrelated hematopoietic stem cell transplantation may be improved if an optimal donor and immunosuppression are chosen...
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemiaAnna Nordlander
Center for Allogenic Stem Cell Transplantation and Department of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 10:195-203. 2004..01), and an HLA-matched donor (P=.01). The association between herpes simplex virus infection and a low frequency of relapse is a new observation and may indicate that viral antigens play a role in the induction of an antileukemic effect...
Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patientsTina Dalianis
Department of Oncology Pathology, Karolinska Institutet, Cancer Center Karolinska R8 01, Karolinska Hospital, 171 76 Stockholm, Sweden
Anticancer Res 31:939-44. 2011....
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodiesO Ringden
Department of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Sweden
Transplantation 66:620-5. 1998..Using unrelated bone marrow, there is an increased risk of graft-versus-host disease (GVHD)...
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantationM Remberger
Centre for Allogeneic Stem Cell Transplantation, and Department of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Sweden
Eur J Haematol 66:50-6. 2001..The cumulative probabilities of relapse were 37% in the both groups. This suggests that the Scandinavian population is more homogeneous with regard to minor histocompatibility antigens important for chronic, but not acute GVHD...
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?Stefan Deneberg
Centre of Haematology M54, Karolinska University Hospital, Huddinge, Stockholm 141 86, Sweden
Med Oncol 24:354-6. 2007..Although no definite conclusions can be drawn from one case this might have implications for the use of Rituximab in cGVHD in ALL patients...
Beta-herpesvirus challenges in the transplant recipientPer Ljungman
Karolinska Institutet, SE 14186 Stockholm, Sweden
J Infect Dis 186:S99-S109. 2002..Diagnosis and treatment of CMV infection is currently more advanced than for HHV-6 and HHV-7...
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignanciesHonar Cherif
Department of Medicine, Division of Haematology, Karolinska Hospital and Institute, Stockholm, Sweden
Scand J Infect Dis 36:593-600. 2004..Early discontinuation of antibiotic therapy in 31 patients with FUO 48 h after defervescence was not associated with an increased rate of fever relapse or mortality compared with a subgroup of 29 patients where therapy was continued...
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeP Ljungman
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 37:439-49. 2006..The introduction of alternative therapies has challenged well-established indications such as imatinib for chronic myeloid leukaemia. An updated report with revised tables and operating definitions is presented here...
Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipientsF-Z Wang
Department of Hematology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 30:521-6. 2002..001). Our data indicate the possibility that HHV-6 can suppress the development of CMV-specific immune responses and thereby could predispose to development of late CMV disease...
Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipientsI Gustafson
Department of Medicine, Infectious Disease Unit, B2 00, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, S 171 76 Stockholm, Sweden
J Clin Virol 43:79-85. 2008..Adenovirus (AdV) infection is a life threatening condition in immunosuppressed patients. Quantitative AdV assays can improve the clinical management of these patients...
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantationBenjamin Edvinsson
Swedish Institute for Infectious Disease Control, Karolinska University Hospital Huddinge, Stockholm, Sweden
APMIS 116:345-51. 2008..These two patients were seropositive for T. gondii. We concluded that monitoring for T. gondii DNA in peripheral blood samples using PCR might be a valuable method for identifying toxoplasma-seropositive stem cell transplant recipients...
Factors associated with poor general health after stem-cell transplantationJoacim Larsen
Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 23300, 141 83 Huddinge, Stockholm, Sweden
Support Care Cancer 15:849-57. 2007..To describe functional status (FS), general health (GH) and symptom distress (SD) from admission to 1 year post-SCT and to identify medical, demographic, and/or patient-reported outcome variables associated with patient-perceived GH...
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplantsPer Ljungman
Department of Haematology, Huddinge University Hospital, Stockholm, Sweden
Blood 99:3050-6. 2002..Survival was similar in each group. Valacyclovir prophylaxis provides a clinically valuable intervention but must be part of an overall strategy for CMV prevention in BMT...
Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genesKatarina Westling
Department of Medicine, Division of Infectious Diseases, Karolinska University Hospital Huddinge, Karolinska Institutet, I 73, SE 141 86 Stockholm, Sweden
Int J Antimicrob Agents 28:292-6. 2006..Susceptibility to newer antibiotics was high; all strains were susceptible to dalbavancin, daptomycin, linezolid and vancomycin...
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patientsZhibing Yun
Department of Clinical Virology, Karolinska Institutet, Huddinge University Hospital, F68, S 141 86 Huddinge, Stockholm, Sweden
J Virol Methods 110:73-9. 2003..This TaqMan PCR was highly sensitive, reproducible, and stable and has served a useful tool for monitoring CMV DNA levels in large number of clinical samples in a routine diagnostic setting for over 1 year...
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survivalUlla Olsson-Stromberg
Department of Medicine, University Hospital, Uppsala, Sweden
Hematol J 5:462-6. 2004..When we opened our study in 1984, the clinical benefit of allogeneic bone marrow transplantation (BMT) was not well known; to follow up the long-time outcome of this treatment was therefore of great interest...
Human herpesvirus-6 infection in solid organ and stem cell transplant recipientsPer Ljungman
Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
J Clin Virol 37:S87-91. 2006..No established therapy exists but both ganciclovir and foscarnet have been reported to have in vitro and in vivo efficacy against HHV-6...
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donorsPer Ljungman
Department of Hematology, Huddinge University Hospital, Stockholm, Sweden
Scand J Infect Dis 34:347-50. 2002..Thus, this strategy can be safely used together with PCR monitoring and preemptive therapy...
Viral infections: current diagnosis and treatmentPer Ljungman
Huddinge University Hospital, Stockholm, Sweden
Hematol J 5:S63-8. 2004
Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantationJoacim Larsen
Department of Nursing, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Cancer Nurs 27:55-64. 2004..To use an instrument that distinguishes between these aspects of the symptom experience may help health care professionals to support the patients through the SCT-process...
Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assaysZ Yun
Division of Clinical Virology, Huddinge University Hospital, Karolinska Institutet, Sweden
Transplantation 69:1733-6. 2000..Real-time monitoring of cytomegalovirus (CMV) infections in transplant patients demands a rapid and high-throughput CMV DNA quantification method...
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow TransplantaO Ringden
Centre for Allogeneic Stem Cell Transplantation, and the Department of Hematology, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
Blood 93:2196-201. 1999..01). In patients with chronic myeloid leukemia (CML) in first chronic phase, 7-year LFS was 72% and 83% in the two groups, respectively...
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantationGayane Avetisyan
Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Transplantation 86:257-63. 2008..Measurement of cellular and humoral immunological responses might increase our understanding of how to estimate a protective response to influenza vaccination...
Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reductionPer Ljungman
Department of Hematology, Huddinge University Hospital, Karolinska Institutet, SE-14186 Stockholm, Sweden
Br J Haematol 125:107-16. 2004
[Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk]Fredrik Jarnbring
, Karolinska Universitetssjukhuset Huddinge
Lakartidningen 103:1741-3. 2006
Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?F Z Wang
BMT Program, Huddinge University Hospital, Karolinska Institute, Sweden
Clin Infect Dis 28:562-8. 1999..Four cases' conditions were improved or they were cured after treatment with either ganciclovir or foscarnet, and one case died of CNS disease despite foscarnet treatment...
Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantationG Avetisyan
Department of Medicine, Division of Haematology, Karolinska Institutet, Karolinska University Hospital in Huddinge, Stockholm 14186, Sweden
Bone Marrow Transplant 38:687-92. 2006..Recovery of CMV-specific immunity might be delayed in patients with CMV disease. These observations suggest that detection of CMV-specific T-cells is useful in assessing the immunity against CMV...
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipientsP Ljungman
Department of Hematology, Huddinge University Hospital, Karolinska Institutet, Sweden
Transplantation 66:1330-4. 1998..Several preventive strategies against cytomegalovirus (CMV) disease have been developed during the last decade. These have frequently been used in combination, and it has been difficult to identify each strategy's contribution...
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationP Ljungman
Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden
Bone Marrow Transplant 31:481-6. 2003..We conclude that cidofovir may be useful against adenovirus after allogeneic hematopoietic stem cell transplantation but additional studies are needed...
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCTG Avetisyan
Division of Haematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 40:865-9. 2007..01). There was no effect as regards the type of conditioning, donor type, stem cell source or acute GVHD. Monitoring the immunity of SCT patients may allow more targeted use of antiviral therapy...
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centresG Gahrton
Department of Medicine, Huddinge Hospital, Sweden
Br J Haematol 113:209-16. 2001..Better supportive treatment and more frequent use of cytokines may also play a role. The improvement in survival was not directly related to the increased use of PBSCs...
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseasesO Ringden
Division of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 39:383-8. 2007..03). Treatment-related mortality was 4 and 15%, and 5-year survival was 89 and 85% in the FBC and MC groups. Although survival was similar, FBC is a promising alternative to MC in non-malignant disorders...
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsK Le Blanc
Hematology Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Leukemia 21:1733-8. 2007..Thus, co-transplantation of MSC resulted in fast engraftment of absolute neutrophil count (ANC) and platelets and 100% donor chimerism, even in three patients regrafted for graft failure/rejection...
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reactionH Omar
Department of Medicine, Huddinge, Division of Haematology, Karolinska Institutet, Stockholm, Sweden
Transpl Infect Dis 11:393-9. 2009..The likelihood of PTLD is increased in the presence of specific risk factors. Monitoring of EBV DNA load and early administration of rituximab in patients with high EBV loads is recommended for high-risk patients...
DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: results from the AIRGENE studyPetter Ljungman
Dept of Cardiology, Karolinska Institutet, Stockholm South Hospital, Stockholm, Sweden
Thromb Res 124:57-64. 2009..Increased levels of interleukin 6 (IL-6), a marker for systemic inflammation, have been associated with cardiovascular morbidity and mortality...
Health-related quality of life in adult survivors after paediatric allo-SCTC M Löf
Department of Paediatrics, CLINTEC, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 43:461-8. 2009..To conclude, childhood SCT did not negatively affect overall health for most of these adult long-term survivors, although poorer HRQoL with psychological and cognitive problems are common...
Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sampleS Panasevich
Unit of Environmental Epidemiology, Institute of Environmental Medicine, Nobels vag 13, Box 210 Karolinska Institutet, SE 171 77 Stockholm, Sweden
Occup Environ Med 66:747-53. 2009..Exposure to elevated levels of ambient air pollutants can lead to adverse cardiovascular effects. Potential mechanisms include systemic inflammation and perturbation of the coagulation balance...
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcomeL Ohrmalm
Department of Medicine, Solna, Infectious Disease Unit, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 46:267-72. 2011..Although AdV DNA was found in peripheral blood by quantitative PCR in 5% of patients undergoing allogeneic HSCT, the present surveillance program did not have a significant effect on the clinical outcome...
Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapyLena von Bahr
Haematology Centre, Department of Clinical Immunology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 18:557-64. 2012..01). We conclude that treatment with early-passage MSCs improved survival in patients with therapy-resistant GVHD. Death from infection was common in MSC-treated patients, but there was no increase in leukemia relapse...
The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhoodCatharina M Löf
Department of Pediatrics, CLINTEC, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden
Pediatr Transplant 15:691-8. 2011..These results indicate the importance of recognizing and attempting to tackle the possible cumulative disadvantage of problems that affect the adult following SCT in childhood...
Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCTHamdy Omar
Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
J Immunother 34:390-6. 2011..Reduced IL-7 responsiveness will aid to monitor patients after HSCT for increased risk to develop EBV-associated PTLD...
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipientsP Ljungman
Department of Hematology, Karolinska University Hospital, Stockholm 14186, Sweden
Bone Marrow Transplant 34:1067-9. 2004..07). A total of 14 patients received a booster dose of an inactivated poliovirus vaccine and all responded. We conclude that poliovirus immunity is retained long term after revaccination in most patients after allogeneic SCT...
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host diseaseP Ljungman
Department of Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 34:589-93. 2004..Since measles is again circulating in many countries and measles is a serious infection after SCT, vaccination should be considered...
Treatment of adenovirus infections in the immunocompromised hostP Ljungman
Department of Haematology, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden
Eur J Clin Microbiol Infect Dis 23:583-8. 2004..New strategies, including pre-emptive therapy, should be tested in prospective, clinical trials. New agents and adoptive transfer of specific T-cells to adenovirus might improve the current situation...
Management of CMV infections: recommendations from the infectious diseases working party of the EBMTP Ljungman
Department of Haematology, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 33:1075-81. 2004
Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot studyP Ljungman
Department of Hematology, Huddinge University Hospital, 14186, Stockholm, Sweden
Support Care Cancer 11:739-41. 2003..Additional studies are needed to assess efficacy of this approach in the prevention of HZ...
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donorsM Remberger
Department of Clinical Immunology, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 30:761-8. 2002..Overall and relapse-free survival were not improved by the occurrence of acute GVHD...
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched graftsG Giraud
Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 41:737-42. 2008..6; P=0.03). However, when analysing HSCT performed with URD or RD grafts separately, BKV (OR 8.5; 95% CI 1.8-19.3; P=0.004) and MC (OR 5.9; 95% CI 1.3-11.3; P=0.009) increased the risk for HC only with a URD, but not with an RD graft...
Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipientsG Avetisyan
Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 36:411-5. 2005..In conclusion, our results suggest that the ELISPOT assay might be used as a complement to serology for monitoring of future influenza vaccine studies in SCT patients...
Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantationJ Larsen
Department of Nursing, Karolinska Institutet, Stockholm, Sweden
Eur J Cancer Care (Engl) 12:71-80. 2003..Patients with advanced disease and patients with multiple myeloma were found to report more SD and poorer FS and HRQOL...
Immune reconstitution and viral infections after stem cell transplantationP Ljungman
Department of Hematology, Huddinge University Hospital, Sweden
Bone Marrow Transplant 21:S72-4. 1998..For this group of patients new innovative preventive and therapeutic strategies are needed...
Definitions of cytomegalovirus infection and disease in transplant recipientsPer Ljungman
Department of Hematology, Huddinge University Hospital, Karolinska Institutet, SE 14186 Stockholm, Sweden
Clin Infect Dis 34:1094-7. 2002..This study seeks to update the definitions of CMV on the basis of recent developments in diagnostic techniques, as well as to add to these definitions the concept of indirect effects caused by CMV...
Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised studyPer Ljungman
Haematology Centre, Karolinska University Hospital, Stockholm, Sweden
Br J Haematol 130:96-8. 2005..Patients treated with monoclonal antibodies for lymphoma had very poor responses. We conclude that two doses of influenza vaccine do not improve the antibody response in patients with haematological malignancies...
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center studyMats Remberger
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 17:1688-97. 2011..The problem of relapse still has to be remedied. Thus, several different developments together have resulted in significantly lower TRM and improved survival after HSCT over the last few years...
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman
Department of Hematology, Karolinska University Hospital, S 14186 Stockholm, Sweden Divison of Hematology, Department of Medicine Huddinge, Karolinska Institutet, S 14186 Stockholm, Sweden
Hematol Oncol Clin North Am 25:151-69. 2011..This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined...
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survivalA C Norlin
Department of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 41:267-73. 2008..04) and an increased incidence of transplant-related mortality (27 vs 9%, P<0.01). IgG levels generally increase after SCT. Persistent low levels of IgG are a risk factor for death after SCT...
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantationA Bjorklund
Hematology Center, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 40:1055-62. 2007..In conclusion, infections occurring later than 6 months after HSCT are important contributors to late non-relapse mortality after HSCT. CMV infection or acute GVHD markedly increase the risk...
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological studyM Enbom
Department of Virology, Swedish Institute for Infectious Disease Control, Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden
J Med Virol 62:498-504. 2000..1 ELISA to be highly specific and also showed a good agreement between two of the immunofluorescence assays. However, generally there was a poor correlation for positive results, indicating the need of further methodological development...
Respiratory virus infections in stem cell transplant patients: the European experienceP Ljungman
Department of Hematology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden
Biol Blood Marrow Transplant 7:5S-7S. 2001..1%. In an 18-month extension, an additional 53 patients with CRV were identified. Results for the combined data were similar to those from the first phase of the study...
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantationG Bogdanovic
Department of Oncology-Pathology, Karolinska Institute, Hudding University Hospital, Stockholm, Sweden
J Clin Microbiol 42:5394-6. 2004..BKV load in combination with acute GVHD discriminated the best, while BKV and viral load alone, but not GVHD, still showed predictive ability for HC...
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioningM Hassan
Laboratory of Hematology, Division of Hematology, Department of Medicine, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 30:833-41. 2002..Moreover, the novel liposomal form of busulphan showed a favorable toxicity profile and seems safe as a part of the high-dose therapy prior to SCT...
Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospitalKatarina Westling
Department of Infectious Diseases, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Scand J Infect Dis 34:316-9. 2002..S. sanguis was the most common subtype (18/47; 38%) in Group A and S. mitis was the major subtype (51/74; 69%) in Group B...
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML GroupUlla Axdorph
Division of Haematology, Department of Medicine, Karolinska Hospital and Institutet, Stockholm, Sweden
Br J Haematol 118:1048-54. 2002..Subsequent SCT/ASCT was feasible for half of the responders (< 65 years), and one individual underwent double ASCT. Novel therapeutic options for CML patients in AP/BP are needed...
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantationC Nilsson
Department of Medicine, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 31:429-35. 2003..We conclude that metronidazole should not be administered simultaneously with Bu to avoid the high plasma levels of Bu, which may lead to severe toxicity and/or treatment related mortality...
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplantsG Gahrton
Department of Medicine, Karolinska Institute and Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 35:609-17. 2005..Therefore, a female donor is as good as a male one for male patients, while for female patients gender disparity is a negative factor for outcome...
Prophylaxis against herpesvirus infections in transplant recipientsP Ljungman
Department of Haematology, Huddinge University Hospital, Karolinska Institutet, Sweden
Drugs 61:187-96. 2001..Finally cidofovir is an interesting agent with broad spectrum antiherpesvirus efficacy. However, because of the drug's toxicity profile, further studies are needed...
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 studyJ Bergh
Radiumhemmet, Karolinska Hospital, Stockholm, Sweden
Lancet 356:1384-91. 2000..We then did a randomised trial to compare this individually tailored FEC regimen with conventional adjuvant chemotherapy followed by consolidation with high-dose chemotherapy with stem-cell support...
Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological diseaseK Westling
Division of Infectious Diseases, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Clin Microbiol Infect 10:899-903. 2004....
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMTP Ljungman
Department of Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 35:737-46. 2005..The EBMT produced recommendations for vaccination of SCT recipients published in Bone Marrow Transplantation in 1995. This paper updates the previous recommendations based on current knowledge...
Pharmacokinetics of liposomal busulphan in manZ Hassan
Department of Medicine, Division of Hematology, Karolinska Institutet at Huddinge University Hospital, Sweden
Bone Marrow Transplant 27:479-85. 2001..146 and r2 = 0.046, respectively). No toxicity related to the liposomal formulation of busulphan was observed. We conclude that LBu is suitable for conditioning before stem cell transplantation...
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantationH Hagglund
Departments of Transplantation Surgery, Clinical Immunology, Paediatrics, and Medicine, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
Blood 92:4568-72. 1998..02), and conditioning with busulphan (P =.02). Our conclusion is that norethisterone treatment should not be used in patients undergoing BMT and heparin prophylaxis did not affect the incidence or mortality of VOD...
CMV retinitis after allogeneic bone marrow transplantation: a report of five casesKajsa Larsson
Department of Haematology, Huddinge University Hospital, SE 14186 Stockholm, Sweden
Transpl Infect Dis 4:75-9. 2002..We conclude that CMV retinitis is a rare but important complication to allogeneic blood stem cell transplantation...
Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complicationsM Machaczka
Department of Haematology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 45:53-61. 2010..01) and in female donors compared with male donors (29 vs 14%, P=0.002). In conclusion, both GA and RA are comparable with regard to BMH. Nevertheless, non-severe intra- and postoperative events were frequent...
Influenza vaccination in hematopoietic SCT recipientsP Ljungman
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden Per Ljungman ki se
Bone Marrow Transplant 42:637-41. 2008..Two vaccine doses are recommended in children below the age of 9 years, who have not been previously vaccinated against influenza. Vaccination of family members, close contacts and health-care workers is recommended...
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationP Ljungman
Dept of Hematology, Huddinge University Hospital, Karolinska Institutet, SE-14186 Stockholm, Sweden
Bone Marrow Transplant 28:479-84. 2001..4%. For influenza A virus infection, the corresponding percentages were 23.0% and 15.3%. This prospective study supports the fact that community-acquired respiratory virus infections cause transplant-related mortality after SCT...
Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokinesN Ihendyane
Department of Medicine, Center for Infectious Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 33:79-85. 2004..04). The study underscores the importance of the host-pathogen interplay in determining the level of inflammation, and hence the severity of disease...
